Jason Okazaki is Chief Executive Officer and President of Assembly BioSciences, Inc. (ASMB). The company reported total compensation of $2,482,987 for fiscal year 2025.
| Salary | $647,500 |
|---|---|
| Bonus | $0 |
| Stock awards | $661,671 |
| Option awards | $573,574 |
| Non-equity incentive plan | $585,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $15,242 |
| Total | $2,482,987 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Assembly BioSciences, Inc. filed April 22, 2026, accession 0001193125-26-170417.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jason Okazaki this page | Chief Executive Officer and President | $2,482,987 |
| William Delaney | Chief Scientific Officer | $1,264,904 |
| Anuj Gaggar | Chief Medical Officer | $1,246,051 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Assembly BioSciences, Inc. compensation brief.
Jason Okazaki's compensation sits inside Assembly BioSciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.